Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lehnert, T.
Sonntag, D.
Konnopka, A.
Riedel‐Heller, S.
and
König, H.‐H.
2012.
The long‐term cost‐effectiveness of obesity prevention interventions: systematic literature review.
Obesity Reviews,
Vol. 13,
Issue. 6,
p.
537.
Kaltenthaler, Eva
Tappenden, Paul
and
Paisley, Suzy
2013.
Reviewing the Evidence to Inform the Population of Cost-Effectiveness Models within Health Technology Assessments.
Value in Health,
Vol. 16,
Issue. 5,
p.
830.
Paisley, S.
2014.
Encyclopedia of Health Economics.
p.
302.
Kaltenthaler, Eva
Essat, Munira
Tappenden, Paul
and
Paisley, Suzy
2014.
IDENTIFICATION AND REVIEW OF COST-EFFECTIVENESS MODEL PARAMETERS: A QUALITATIVE STUDY.
International Journal of Technology Assessment in Health Care,
Vol. 30,
Issue. 3,
p.
333.
Shemilt, I.
Wilson, E.
and
Vale, L.
2014.
Encyclopedia of Health Economics.
p.
218.
Zechmeister-Koss, Ingrid
Schnell-Inderst, Petra
and
Zauner, Günther
2014.
Appropriate Evidence Sources for Populating Decision Analytic Models within Health Technology Assessment (HTA).
Medical Decision Making,
Vol. 34,
Issue. 3,
p.
288.
Cooper, Chris
Rogers, Morwenna
Bethel, Alison
Briscoe, Simon
and
Lowe, Jenny
2015.
A mapping review of the literature on UK‐focused health and social care databases.
Health Information & Libraries Journal,
Vol. 32,
Issue. 1,
p.
5.
Edlin, Richard
McCabe, Christopher
Hulme, Claire
Hall, Peter
and
Wright, Judy
2015.
Cost Effectiveness Modelling for Health Technology Assessment.
p.
15.
Paisley, Suzy
2016.
Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.
PharmacoEconomics,
Vol. 34,
Issue. 6,
p.
597.
Brazier, John
Ara, Roberta
Azzabi, Ismail
Busschbach, Jan
Chevrou-Séverac, Hélène
Crawford, Bruce
Cruz, Luciane
Karnon, John
Lloyd, Andrew
Paisley, Suzy
and
Pickard, A. Simon
2019.
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.
Value in Health,
Vol. 22,
Issue. 3,
p.
267.
Krebs, Emanuel
Enns, Benjamin
Wang, Linwei
Zang, Xiao
Panagiotoglou, Dimitra
Del Rio, Carlos
Dombrowski, Julia
Feaster, Daniel J.
Golden, Matthew
Granich, Reuben
Marshall, Brandon
Mehta, Shruti H.
Metsch, Lisa
Schackman, Bruce R.
Strathdee, Steffanie A.
Nosyk, Bohdan
and
Cipriano, Lauren
2019.
Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis.
PLOS ONE,
Vol. 14,
Issue. 5,
p.
e0217559.
Zang, Xiao
Krebs, Emanuel
Wang, Linwei
Marshall, Brandon D. L.
Granich, Reuben
Schackman, Bruce R.
Montaner, Julio S. G.
and
Nosyk, Bohdan
2019.
Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review.
PharmacoEconomics,
Vol. 37,
Issue. 10,
p.
1219.
Husereau, Don
Drummond, Michael
Augustovski, Federico
de Bekker-Grob, Esther
Briggs, Andrew H.
Carswell, Chris
Caulley, Lisa
Chaiyakunapruk, Nathorn
Greenberg, Dan
Loder, Elizabeth
Mauskopf, Josephine
Mullins, C. Daniel
Petrou, Stavros
Pwu, Raoh-Fang
and
Staniszewska, Sophie
2022.
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.
Value in Health,
Vol. 25,
Issue. 1,
p.
10.
Kunst, Natalia
Burger, Emily A.
Coupé, Veerle M. H.
Kuntz, Karen M.
and
Aas, Eline
2024.
A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework.
PharmacoEconomics,
Vol. 42,
Issue. 4,
p.
363.
Tamlyn Anne, Rautenberg
Downes, Martin
Simoncini, Tommaso
Yu, Qi
Ren, Mulan
Wang, Yaping
Graziano, Custodio Marcelo
and
Kim, Kyoo
2024.
Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China.
Journal of Medical Economics,
Vol. 27,
Issue. 1,
p.
16.